Antimicrobial stewardship, Antibiotic consumption, Days of therapy, Defined daily dose
Citation Information :
Zirpe K, Kapse US, Gurav SK, Tiwari AM, Deshmukh AM, Suryawanshi PB, Bhoyar AP, Wankhede PP, Desai D, Suryawanshi R, John R, Bhagat S. Impact of an Antimicrobial Stewardship Program on Broad Spectrum Antibiotics Consumption in the Intensive Care Setting. Indian J Crit Care Med 2023; 27 (10):737-742.
Background and objectives: Antibiotics are the most commonly exploited agents in intensive care units. An antimicrobial stewardship program (ASP) helps in the optimal utilization of antibiotics and prevents the development of antibiotic resistance. The aim of this study was to assess the impact of ASP on broad-spectrum antibiotic consumption in terms of defined daily dose (DDD) and days of therapy (DOT) before and after the implementation of an ASP.
Materials and methods: It was a prospective, quasi-experimental, pre- and post-study. Group A consisted of 5 months of ASP data, ASP activities were implemented during the next 2 months and continued. Group B (post-ASP) data was collected for the next 5 months. Total and individual DDDs and DOTs of broad-spectrum antibiotics utilized were compared between group A and group B.
Results: Total DDDs used per 100 patient bed days were reduced by 18.72% post-ASP implementation (103.46 to 84.09 grams). The total DOT per 100 patient bed days used was 90.91 vs 71.25 days (21.62% reduction). As per the WHO classification of antibiotics use, the watch category (43.4% vs 43.04%) as well as reserve category (56.6% vs 56.97%) used between the two groups were found similar. The average length of stay (8.9 ± 2 days) after ASP was found significantly lesser than baseline (10.8 ± 3.4 days) (p < 0.05), however, there was no significant change in mortality between the two groups.
Conclusion: Antimicrobial stewardship program implementation may reduce overall antibiotic consumption both in terms of DDD and DOT.
Hecker MT, Aron DC, Patel NP, Lehmann MK, Donskey CJ. Unnecessary use of antimicrobials in hospitalized patients: Current patterns of misuse with an emphasis on the antianaerobic spectrum of activity. Arch Intern Med 2003;163(8):972–978. DOI: 10.1001/archinte.163.8.972.
Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: Systematic review and meta-analysis. BMJ 2010;340:c2096. DOI: 10.1136/bmj.c2096.
Rosengren LB, Waldner CL, Reid-Smith RJ. Associations between antimicrobial resistance phenotypes, antimicrobial resistance genes, and virulence genes of fecal Escherichia coli isolates from healthy grow-finish pigs. Appl Environ Microbiol 2009;75(5):1373–1380. DOI: 10.1128/AEM.01253-08.
Charani E, Holmes AH. Antimicrobial stewardship programmes: The need for wider engagement. BMJ Qual Saf 2013;22(11):885–887. DOI: 10.1136/bmjqs-2013-002444.
World Health Organization. Global action plan on antimicrobial resistance. 2015. Available from: https://apps.who.int/iris/handle/10665/193736.
Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009;302(21):2323–2329. DOI: 10.1001/jama.2009.1754.
Kolár M, Urbánek K, Látal T. Antibiotic selective pressure and development of bacterial resistance. Int J Antimicrob Agents 2001;17(5):357–363. DOI: 10.1016/s0924-8579(01)00317-x.
Llaca-Díaz JM, Mendoza-Olazarán S, Camacho-Ortiz A, Flores S, Garza-González E. One-year surveillance of ESKAPE pathogens in an intensive care unit of Monterrey, Mexico. Chemotherapy 2012;58(6):475–481. DOI: 10.1159/000346352.
Khan AU, Maryam L, Zarrilli R. Structure, genetics and worldwide spread of New Delhi metallo-β-lactamase (NDM): A threat to public health. BMC Microbiol 2017;17(1):101. DOI: 10.1186/s12866-017-1012-8.
Al-Tawfiq JA, Momattin H, Al-Ali AY, Eljaaly K, Tirupathi R, Haradwala MB, et al. Antibiotics in the pipeline: A literature review (2017-2020). Infection 2022;50(3):553–564. DOI: 10.1007/s15010-021-01709-3.
Hansson K, Brenthel A. Imagining a post-antibiotic era: A cultural analysis of crisis and antibiotic resistance. Med Humanit 2022;48(3):381–388. DOI: 10.1136/medhum-2022-012409.
Doron S, Davidson LE. Antimicrobial stewardship. Mayo Clin Proc 2011;86(11):1113–1123. DOI: 10.4065/mcp.2011.0358.
Mahmoudi L, Sepasian A, Firouzabadi D, Akbari A. The impact of an antibiotic stewardship program on the consumption of specific antimicrobials and their cost burden: A hospital-wide intervention. Risk Manag Healthc Policy 2020;13:1701–1709. DOI: 10.2147/RMHP.S265407.
WHO Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC classification and DDD assignment 2018. Oslo (Norway): 2017.
Barlam TF, Cosgrove SE, Abbo LM, MacDougall C, Schuetz AN, Septimus EJ, et al. Implementing an antibiotic stewardship program: Guidelines by the Infectious Diseases Society of America and The Society for Healthcare Epidemiology of America. Clin Infect Dis 2016;62(10):e51–e77. DOI: 10.1093/cid/ciw118.
Koya SF, Ganesh S, Selvaraj S, Wirtz VJ, Galea S, Rockers PC. Consumption of systemic antibiotics in India in 2019. Lancet Reg Health Southeast Asia 2022;4:100025. DOI: 10.1016/j.lansea.2022.100025.
WHO. WHO antibiotic categorization. 2019. Available from: https://aware. essentialmeds.org/groups.
Rungta N, Zirpe KG, Dixit SB, Mehta Y, Chaudhry D, Govil D, et al. Indian society of critical care medicine experts committee consensus statement on ICU planning and designing, 2020. Indian J Crit Care Med 2020;24(Suppl 1):S43–S60. DOI: 10.5005/jp-journals-10071-G23185.
Zay Ya K, Win PTN, Bielicki J, Lambiris M, Fink G. Association between antimicrobial stewardship programs and antibiotic use globally: A systematic review and meta-analysis. JAMA Netw Open 2023;6(2):e2253806. DOI: 10.1001/jamanetworkopen.2022.53806.
Onorato L, Macera M, Calò F, Monari C, Russo F, Iovene MR, et al. The effect of an Antimicrobial Stewardship Programme in two intensive care units of a Teaching Hospital: An interrupted time series analysis. Clin Microbiol Infect 2020;26(6):782.e1–782.e6. DOI: 10.1016/j.cmi.2019.10.021.
Panditrao A, Shafiq N, Kumar-M P, Sekhon AK, Biswal M, Singh G, et al. Impact of an antimicrobial stewardship and monitoring of infection control bundle in a surgical intensive care unit of a Tertiary-care Hospital in India. J Glob Antimicrob Resist 2021;24:260–265. DOI: 10.1016/j.jgar.2021.01.003.
Chowdhury SS, Sastry AS, Sureshkumar S, Cherian A, Sistla S, Rajashekar D. The impact of antimicrobial stewardship programme on regulating the policy adherence and antimicrobial usage in selected intensive care units in a Tertiary Care Center - A prospective interventional study. Indian J Med Microbiol 2020;38(3 & 4):362–370. DOI: 10.4103/ijmm.IJMM_20_326.
Trotter NE, Slight SP, Karimi R, Bates DW, Sheikh A, Weir CJ, et al. The effect of digital antimicrobial stewardship programmes on antimicrobial usage, length of stay, mortality and cost. Informatics in Medicine Unlocked, 2023:37:101183. DOI: 10.1016/j.imu.2023.101183.
Aiesh BM, Nazzal MA, Abdelhaq AI, Abutaha SA, Zyoud SH, Sabateen A. Impact of an Antibiotic Stewardship Program on antibiotic utilization, bacterial susceptibilities, and cost of antibiotics. Sci Rep 2023;13(1):5040. DOI: 10.1038/s41598-023-32329-6.
Morris AM. Antimicrobial Stewardship Programs: Appropriate measures and metrics to study their impact. Curr Treat Options Infect Dis 2014;6(2):101–112. DOI: 10.1007/s40506-014-0015-3.
Khilnani GC, Zirpe K, Hadda V, Mehta Y, Madan K, Kulkarni A, et al. Guidelines for antibiotic prescription in intensive care unit. Indian J Crit Care Med 2019;23(Suppl 1):S1–S63. DOI: 10.5005/jp-journals-10071-23101.
Khdour MR, Hallak HO, Aldeyab MA, Nasif MA, Khalili AM, Dallashi AA, et al. Impact of antimicrobial stewardship programme on hospitalized patients at the intensive care unit: A prospective audit and feedback study. Br J Clin Pharmacol 2018;84(4):708–715. DOI: 10.1111/bcp.13486.